<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report
(Date of earliest event reported):
September 11, 2000
GELTEX PHARMACEUTICALS, INC.
(Exact Name of Registrant as Specified in Charter)
<TABLE>
Delaware 0-26872 04-3136767
-------- ------- ----------
<S> <C> <C>
(State or Other Jurisdiction (Commission File Number) (I.R.S. Employer Identification No.)
of Incorporation)
</TABLE>
153 SECOND AVENUE,
WALTHAM, MASSACHUSETTS 02451
(Address of principal executive office and zip code)
Registrant's telephone number, including area code:
(781) 290-5888
Page 1
<PAGE> 2
ITEM 5. OTHER EVENTS.
On September 11, 2000, the Registrant and Genzyme Corporation ("Genzyme")
publicly disseminated a press release announcing that they had entered into an
Agreement and Plan of Merger, dated as of September 11, 2000 (the "Merger
Agreement"), which sets forth the terms and conditions of the proposed merger of
the Registrant with and into a subsidiary of Genzyme (the "Merger") pursuant to
which the Registrant will become a wholly owned subsidiary of Genzyme. A copy of
the joint press release of the Registrant and Genzyme with respect to the Merger
is included herein as Exhibit 99.1. The joint press release is incorporated by
reference into this Item 5 and the foregoing description of the press release is
qualified in its entirety by reference to this exhibit.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits.
99.1 The Registrant's Press Release Dated September 11, 2000.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
GELTEX PHARMACEUTICALS, INC.
By: /s/ Mark Skaletsky
-------------------------------
Mark Skaletsky
President and Chief Executive Officer
Date: September 11, 2000
Page 2
<PAGE> 3
EXHIBIT INDEX
Exhibit Sequential
Number Description Page Number
------- ----------- -----------
99.1 The Registrant's Press Release dated 4
September 11, 2000, is filed
herewith.
Page 3
